We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Ondine Biomedical Inc. | LSE:OBI | London | Ordinary Share | CA68234M2058 | COM SHS NPV (CDI) |
Price Change | % Change | Share Price | Bid Price | Offer Price | High Price | Low Price | Open Price | Shares Traded | Last Trade | |
---|---|---|---|---|---|---|---|---|---|---|
0.00 | 0.00% | 7.75 | 7.50 | 8.00 | 7.75 | 7.55 | 7.75 | 13,966 | 08:00:05 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
Biological Pds,ex Diagnstics | 1.2M | -14.41M | -0.0357 | -2.17 | 31.31M |
Date | Subject | Author | Discuss |
---|---|---|---|
06/8/2024 06:35 | We'll look who flogged eh!Bitterness so sad to see. Fortunately you aren't the market mover you think you are. | premium beeks | |
06/8/2024 06:21 | Still no news regarding the pivotal US trials , another placing not too far away hmmmm best to stay on the side lines until news of US trials which are now DELAYED NO ONE SHOULD LISTEN TO THIS LOSER AFTER HIS LOSSES IN CLCO | z1co | |
06/8/2024 06:05 | Very nice RNS! | premium beeks | |
04/8/2024 16:30 | yes there is plenty of time to get in once things are clearer.no point taking the risk and holding now.a placing is around the corner anyway | purple11 | |
01/8/2024 11:16 | Well it would seem that DEST has been practically stolen from investors by the BOD on the premise (or pretence) that it would be easier to finance the development of assets outside of the market. Funny, that is usually why companies go from private to public. I cannot trust this BOD to take a leaf out of their book by doing the same so it would be madness to rely on the hope that they would not do so. Surely its a case of wait to see how things unfold now before taking the risk? | marvelman | |
24/7/2024 07:10 | im sitting on the sidelines until there is visability | purple11 | |
22/7/2024 00:32 | Phase 3 Trial15 Jul 2024 20:27 The proposed de-listing of Destiny prompted me to think about Ondine’s phase 3 trial. At the investor meets company event on 10/06/24, it was stated that the phase 3 trial is being targeted to start in Q3 this year. Given the fact that Destiny’s phase 3 trial was estimated to cost circa £25m, has anyone any thoughts on how Ondine will fund their phase 3 trial? | purple11 | |
16/7/2024 06:56 | no i didnt | purple11 | |
15/7/2024 10:32 | ive made over 2000 in MATD so far so not bothered | purple11 | |
15/7/2024 09:55 | loss of £40 so negligable hoping to buy back in @7p | purple11 | |
15/7/2024 09:29 | out again. going to wait and see what price the next placing comes in at. if theres a sell off before like last time may be able to pick up a holding far cheaper. | purple11 | |
09/7/2024 21:44 | thats cos im a Hippy chick and i do all the drugs | purple11 | |
09/7/2024 21:44 | i just dance in the waves runningxinxwaves | purple11 | |
09/7/2024 20:01 | LOL You'll be out at 8.50p CLOWN | z1co | |
09/7/2024 18:32 | im betting on up to 10p area gl | purple11 | |
09/7/2024 15:31 | there is a rising Bullish Wedge on the monthly that indicates a decisive move up or down is imminent | purple11 | |
09/7/2024 14:48 | LOL Your imaginary trade hahahah CLOWN | z1co |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions